Intracellular ion fluxes emerge as critical actors of immunoregulation but still remain poorly explored. Here we investigated the role of the redundant cation channels TMEM176A and TMEM176B (TMEM176A/B) in RORgt + cells and conventional dendritic cells (cDCs) using germline and conditional double knock-out (DKO) mice. While Tmem176a/b appeared surprisingly dispensable for the protective function of Th17 and group 3 innate lymphoid cells (ILC3s) in the intestinal mucosa, we found that they were required in cDCs for optimal antigen processing and presentation to CD4 + T cells. Using a real-time imaging method, we show that TMEM176A/B accumulate in dynamic post-Golgi vesicles preferentially linked to the late endolysosomal system and strongly colocalize with HLA-DM. Together, our results suggest that TMEM176A/B ion channels play a direct role in the MHC II compartment (MIIC) of DCs for the fine regulation of antigen presentation and naive CD4 + T cell priming.
Introduction
Multiple ion channels and transporters are expressed in both innate and adaptive immune cells to control various vital functions, from membrane potential regulation to receptor signaling or migration 1 . The role of ion flux has notably been fully appreciated following the molecular characterization of the store-operated Ca 2+ entry (SOCE) through Ca 2+ release-activated Ca 2+ (CRAC) channels mediated by the ORAI/STIM complex, best characterized in T cells. However, this system appears dispensable for key functions of macrophages and dendritic cells (DCs) while Ca 2+ signaling remains critical in these cells 2, 3 . This observation points to the importance of alternative systems, yet to be discovered, that regulate the intracellular and luminal concentrations of Ca 2+ but also other ions including Na + , K + , Cl -, Mg 2+ or Zn 2+ for the control of immune responses. In comparison with the plasma membrane, there is still a paucity of studies investigating the role of intracellular ion channels and transporters, notably in DCs 4 , that could provide major insights into the understanding of new immunomodulatory mechanisms.
We previously showed that the co-regulated genes Tmem176a and Tmem176b encode redundant acidsensitive, non-selective, cation channels 5,6 whose precise functions remain largely unknown in vivo.
Transcriptomic, SNP or epigenetic analysis have associated these homolog genes with different pathologies such as multiple sclerosis 7 , chronic obstructive pulmonary disease (COPD) 8 or age-related macular degeneration (AMD) 9 . These findings suggest an important role of Tmem176a/b in the development of inflammatory diseases thus emphasizing the need to identify the immune cell types and the functions in which they are predominantly involved.
We initially cloned Tmem176b (originally named Torid) as an over-expressed gene encoding an intracellular four-span transmembrane protein in myeloid cells infiltrating non-rejecting allografts 10 . We later demonstrated its contribution to the suppressive function of ex vivo-generated tolerogenic DCs through antigen crosspresentation by allowing cation (Na + ) counterflux required for progressive endophagosomal acidification 5 .
However, the function of this ion flux in the homeostasis and physiological response of conventional DCs has not been explored and is likely achieved by both TMEM176A and TMEM176B in a redundant fashion 6 .
Unexpectedly, besides myeloid cells, we and others reported a strong expression of Tmem176a and Tmem176b in the retinoic-acid-receptor-related orphan receptor-γt-positive (RORγt + ) lymphoid cell family, also referred Lancien et al.
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to as type 3 (or type 17) immune cells, producing the prototypical cytokines IL-17 and IL-22 and including Th17 CD4 + T cells, gdT17 cells, group 3 innate lymphoid cells (ILC3s) and NKT17 cells 6, [11] [12] [13] [14] . Moreover, the Littman group included Tmem176a/b in the restricted group of 11 genes whose expression is directly dependent on RORγt in Th17 cells 15 . However, in our previous study, we found no or only modest effect of Tmem176b single deficiency in different models of autoinflammation linked to type 3 immunity 6 . We speculated that the absence of Tmem176b could be efficiently compensated by its homolog Tmem176a, located in the same genomic locus, thus masking possible phenotypic alterations.
Here we have used germline and conditional ("floxed") double knock-out (DKO) mice to unequivocally determine the importance of Tmem176a and Tmem176b in the biology of RORgt + cells and conventional DCs in vivo. In that respect, this is the first study exploring the consequence of Tmem176a/b double deficiency in vivo. Furthermore, we have combined these functional results with the elucidation of the precise trafficking of both proteins using a real-time imaging method. Our findings show that, while Tmem176a/b appear surprisingly dispensable for RORgt + cell functions, these genes are required in the MHC II pathway in DCs for efficient priming of naive CD4 + T cells.
Lancien et al.
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Results
Generation of germline and conditional double KO (DKO) mice simultaneously targeting Tmem176a and Tmem176b
Tmem176a and Tmem176b are homolog genes encoding structurally similar four-span transmembrane proteins 6, 10, 16 (Figure 1A) . In the immune system, our previous studies 6, 10, 17 combined with the analysis of Immuno-Navigator 18 and Immgen 19 public databases (Figure S1) indicate that Tmem176a and Tmem176b are tightly co-regulated and highly expressed both in conventional DCs and in the RORgt + cell family (depicted in Figure 1B ). Taken together, these observations along with reported evidence of genetic compensation in Tmem176b −/− single KO mice 6 strongly suggested the need to simultaneously target both genes to decipher their function.
As described previously in a methodological study 20 , we generated a germline double KO (DKO) mouse ( Figure 1C) in the pure C57BL/6N genetic background. Homozygous DKO mice were born in a Mendelian ratio and appeared normal, without any significant difference in weight from control WT littermates, suggesting that Tmem176a/b are not absolutely required, or can be sufficiently compensated, during development.
In order to clearly associate a cell type with a potential phenotypic observation resulting from Tmem176a/b deficiency, we also engaged in the generation of a conditional DKO mouse (Tmem176a/b flox ) ( Figure 1D ) that we crossed to Rorc(γt)-Cre and CD11c-Cre (Itgax-Cre) mice to target RORgt + and CD11c + cells, respectively.
Tmem176a/b DKO mice exhibit normal ILC3 and Th17 distribution and RORgt cell-dependent protective functions in the gut mucosa
Owing to the high expression of Tmem176a/b in RORγt + cells, we focused our attention on the intestinal mucosa where these cells preferentially localize to exert their sentinel function in response to the gut microbiota 21 . Flow cytometry analysis (gating strategy depicted in Figure S2A -B) of CD4 + T cells and ILCs in the small intestine and colon lamina propria revealed no differences in the proportions of Th17 or ILC3 subsets between WT and DKO mice (Figure 2A) . Furthermore, in vitro cytokine production of intestinal CD4 + T cells and ILCs was not affected by Tmem176a/b double deficiency (Figure 2B) . Concordant with this, we did not detect any significant change in the level of expression of Rorc2 (the isoform encoding RORgt), Il23r, Il22, Il17a or Il17f as well as target genes of the IL-22/IL17 axis in the small intestine and colon of DKO mice ( Figure S2C) .
To test whether Tmem176a/b could play a role in RORγt + cells in the context of inflammatory responses in the gut mucosa, we used the injury-induced self-resolving model of dextran sodium sulfate (DSS)-induced acute colitis in which Th17/ILC3-derived IL-22 is pivotal to restore barrier integrity upon epithelial damage 22, 23 .
However, both germline DKO and Tmem176a/b fl/fl Rorc-Cre +/conditional mice exhibited a similar response to DSS when compared to control mice ( Figure 2C ). Next, we used an infectious colitis model using
Citrobacter rodentium, a mouse attaching and effacing bacterial pathogen considered as an excellent model of clinically important human gastrointestinal pathogens and against which ILC3s and Th17 have been shown to play a protective and redundant role 11, 24, 25 . As shown in Figure 2D , Tmem176a/b deficiency did not hamper the mouse resistance to this infection. Moreover, although fecal Citrobacter rodentium bacterial loads detected Lancien et al.
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by qPCR appeared increased in RORgt-specific conditional DKO, this difference did not reach statistical significance and was not found in germline DKO mice compared to respective control mice (Figure 2E) .
Thus, these results suggest that Tmem176a/b are not critical for the development and protective functions of ILC3s and Th17 in the intestinal mucosa.
DCs develop normally in Tmem176a/b-deficient mice
Next, we investigated the effect of Tmem176a/b double deficiency in the biology of conventional DCs (cDCs).
First, because both genes are highly expressed in the majority of hematopoietic precursors including cDC progenitors ( Figure 1B and Figure S1 ), we assessed their frequency in the bone marrow but found no alteration in DKO mice ( Figure 3A and Figure S3 ). Accordingly, the percentages and absolute numbers of CD11c high MHC II + cells in the spleen and, within this population, the proportions of the two main conventional DC subsets, namely cDC1 (CD11b -CD8a + ) and cDC2 (CD11b + CD8a -), were similar between WT and DKO mice ( Figure 3B ). Furthermore, MHC I, MHC II, CD80 (B7-1) and CD86 (B7-2) surface expression on cDC1 and cDC2 were not affected by Tmem176a/b deficiency and LPS stimulation elicited an equally strong upregulation of MHC II, CD80 and CD86 at the surface of both WT and DKO cDC subsets ( Figure 3C ).
Finally, purified spleen cDCs from WT and DKO mice produced similar basal levels of IL-12 and IL-6 that were both increased with the addition of LPS (Figure D) .
In the absence of obvious developmental abnormalities of cDCs, we sought to identify dysregulated cellular pathways resulting from the absence of Tmem176a/b. Chromatin dynamics reflect with great sensitivity gene regulation and play important roles in immune functions such as trained innate immunity 26 or T cell effector/memory differentiation 27 . To investigate whether epigenetic alterations are present in DKO cDCs we FACS-sorted CD11c high MHC II + cells and performed chromatin immunoprecipitation by targeting lysine H3K27 acetylation (H3K27ac) followed by sequencing (ChIP-seq) to detect active promoters and enhancers (epigenomics road map). We found that 962 enhancers were significantly differentially acetylated (DA) between WT and DKO cDCs (Figure 3E-F) . Interestingly, one of the most significantly DA gene regulatory region covered the entire Cd74 gene ( Figure 3G ) and MHC gene ontology analysis included antigen processing and MHC II protein molecules ( Figure 3H) . Together, these data suggest that Tmem176a/b deficiency could impact intracellular processes of the MHC II pathway and lead to selective genetic 9/36
adaptations. Further supporting a role of Tmem176a/b in the MHC II pathway, we found that both homologs were clearly over-expressed in cDC2 when compared to B cells, pDCs and cDC1 (Figure 3I) , consistent with the propensity of this subset in priming naive CD4 + T cells through MHC II antigen presentation 28 . 
Tmem176a/b are required for optimal presentation of exogenous antigens to CD4 + T cells by DCs
To determine whether Tmem176a/b are required in DCs for antigen presentation in vivo via MHC I or MHC II molecules, we set out to test different models of dominant CD8 + or CD4 + T cell responses.
First, using a minor histocompatibility transplantation model in which male skin is grafted onto female recipients, we found that WT and DKO exhibited the same rate of graft rejection (Figure 4A) , suggesting that CD8 + T cell priming and effector functions were not impaired in the absence of Tmem176a/b. Next, we examined whether anti-tumor immune responses could be influenced by Tmem176a/b deficiency. Notably, we hypothesized that DKO could exhibit enhanced anti-tumor immunity owing to a recent study proposing that targeting Tmem176b could improve anti-tumor CD8 + T-cell response by de-repressing inflammasome activation in myeloid cells 29 . Subcutaneous injection of OVA-expressing EG7 thymoma led to detectable tumors within two weeks in all mice and, consistently with the relatively immunogenic nature of this cell line in our experimental conditions, tumor regression was then observed in a large fraction of the mice but without significant difference between WT and DKO mice (Figure 4B and Figure S4 ). Furthermore, Tmem176a/b deficiency did not impact tumor growth and mouse survival with two aggressive tumor cell lines, MCA101-sOVA fibrosarcoma and B16-OVA melanoma (Figure 4B and Figure S4) . Thus, our results show that the absence of Tmem176a and Tmem176b does not prevent nor enhance CD8 + T-cell responses. To evaluate CD4 + T-cell responses in vivo, we first used the model of experimental autoimmune-encephalomyelitis (EAE) induced by MOG35-55 peptide or MOG1-125 protein immunization (Figure 4C) . Interestingly, whereas EAE developed similarly between WT and DKO mice with MOG peptide immunization (Figure 4D) , DKO mice appeared less susceptible if the MOG protein was used (Figure 4E) , thus pointing to a specific role of Tmem176a/b in antigen processing before peptide-MHC II complex display at the surface. Because of the high variability of this model, we next turned to a model of delayed-type hypersensitivity (DTH) (Figure 4F) .
Again, we observed that DKO mice differed from WT mice for the DTH response upon challenge in the footpad only if the whole protein was used for the immunization (Figure 4G-H) . Taken together, these data suggest that Tmem176a/b deficiency selectively affects the intracellular processing of exogenous antigens for naive CD4 + T-cell priming.
To further test this hypothesis, we directly assessed antigen-specific T-cell proliferation in WT and DKO mice using naive OVA-specific CD8 + and CD4 + T cells (Figure 5A) . It is important to note that cDCs are strictly required in this system to induce activation and proliferation of naive T cells 30 . As shown in Figure 5B -C, CD4 + T cell proliferation was markedly diminished in DKO mice in comparison to WT mice whereas CD8 + proliferation was not. Importantly, this alteration was not observed in Tmem176a/b fl/fl Rorc-Cre +/conditional mice (Figure 5D ) but was replicated, although to a lesser extent than in germline DKO mice, in Tmem176a/b fl/fl CD11c-Cre +/mice (Figure 5E) .
In vitro antigen-specific CD4 + T-cell proliferation was also significantly decreased in the absence of Figure S5) .
In conclusion, these results show that Tmem176a/b have an intrinsic function in DCs to allow efficient presentation of exogenous antigens onto MHC II molecules and priming of naive CD4 + T cells.
Tmem176a/b-deficient cDCs exhibit normal antigen uptake and degradation but dysregulated H2-M expression selectively in cDC2
Antigen presentation by MHC II molecules is achieved through a series of complex events (depicted in Figure 6A ) beginning with the uptake and mild degradation of exogenous antigens and including finely regulated processes in the specialized MHC II compartment (MIIC) 31 . Both OVA endocytosis and degradation were similar in WT and DKO cDCs (Figure 6B) , indicating that altered MHC II-mediated antigen presentation by Tmem176a/b DCs cannot be explained by a defect in the initial steps of antigen processing.
To determine whether Tmem176a/b deficiency could influence the surface or intracellular levels of key players in the MHC II pathway, we analyzed the expression of MHC II (I-A b ), Ii (invariant chain), H2-M and H2-O in splenic B cells, cDC1 and cDC2 by flow cytometry (Figure 6C) . As expected, cDC1 exhibited the highest levels of intracellular MHC II, Ii and H2-O whereas H2-M was primarily expressed in cDC2, an equilibrium concordant with the intrinsic efficiency of this subset in MHC II processing 28 . Strikingly, while we did not detect aberrant expression of these molecules at the surface of DKO cells, we found that, intracellular H2-M was paradoxically and selectively over-expressed in the cDC2 subset of DKO mice compared to WT mice (Figure 6C, lower left panel) .
Taken together, these data suggest that Tmem176a/b-mediated function is directly involved in the MIIC for optimal MHC II antigen loading or trafficking. 
TMEM176A and TMEM176B traffic in dynamic vesicles between the Golgi apparatus and the endolysosomal compartments
To gain insight into the intracellular function of TMEM176A/B ion channels, we aimed to elucidate their subcellular localization that remains elusive as different studies reached different conclusions 5, 6, 32 . To this end, we used the Retention Using Selective Hooks (RUSH) system 33 , a two-state assay allowing fluorescence-based analysis of intracellular trafficking in living cells at physiological temperature (Figure 7A) . We performed dual-color imaging using multiple organelle-specific proteins or probes (Figure 7B) to track the intracellular fate of TMEM176A/B from the endoplasmic reticulum (ER). We used HeLa cells as they allow higher resolution of intracellular compartments compared to immune cells. Addition of biotin triggered a rapid change in the TMEM176B signal from a network of tubular elements characteristic of the ER to a pattern reminiscent of the Golgi apparatus but which rapidly evolved into multiple dynamic vesicles (Figure 7C and Supplementary Video 1). TMEM176A and TMEM176B exhibited a very similar intracellular dynamic, as measured by strong colocalization throughout the time of acquisition (Figure 7D and Supplementary Video 2).
Confirming our previous hypothesis that TMEM176B traffics through but does not accumulate in the Golgi apparatus 6 Video 3) . We then examined a variety of markers depicted in Figure 7G . We did not, or only marginally, observe accumulation at the plasma membrane, a result that was confirmed by co-imaging with CD44. Interestingly, TMEM176B-bearing vesicles could interact with RAB5 + early endosomes as well as with RAB7 + late endosomes. We generated a LAMP1 (CD107a) RUSH construct to best reveal endolysosomes and also observed a strong association with TMEM176B trafficking during the post-Golgi time frame. Of interest, TMEM176B could be found colocalized with TNF or TfR (transferrin receptor), during the late events of endocytosis/recycling of these proteins. However, TMEM176B
was not associated with RAB4, a marker of recycling endosomes. Although we cannot rule out alternate recycling pathways, these result suggest that TMEM176A/B follow a relatively selective route among the various vesicular compartments of the cell. In this line, TMEM176B did not traffic through mitochondria labeled by the Mitotracker probe but was significantly associated with Lysotracker that preferentially marks Lancien et al.
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acidic vesicles. Moreover, we found some colocalization signals using a cation-dependent mannose-6phosphate receptor (CD-MPR) RUSH construct but even stronger association with the monomeric clathrin adaptor GGA1, known to decorate the carrier vesicles budding from the TGN and merging toward the endosomes 34 .
Taken together, these data show that TMEM176A/B ion channels preferentially localize in the late endosomal compartment and in vesicular vesicles between the Golgi and the endolysosomal system.
TMEM176B colocalizes with HLA-DM in MHC II-expressing cells
Given the requirement of Tmem176a/b in MHC II antigen presentation, the selective alteration of H2-M expression in cDC2 and the preferential trafficking of TMEM176A/B in the late endosomal compartment, we asked whether these ion channels could localize in the MIIC. To recapitulate the MHC II pathway in HeLa cells, we used the HeLa-CIITA cell line that stably expresses the transactivator CIITA 35 . To reveal MHC II (HLA-DR) and HLA-DM localization in these cells, we used plasmid constructs expressing YFP tagged to the beta or alpha chains of each molecule, respectively, as described in Zwarts et al. 36 . Colocalized signals were detected between TMEM176B and HLA-DR, mostly in intracellular vesicles (Figure 7H) . However, a more pronounced association was observed with HLA-DM in intracellular compartments presumably highlighting the MIIC.
Thus, these results strongly suggest that TMEM176A/B exert their function directly in the MIIC to contribute to efficient MHC II peptide loading and/or trafficking. 
Discussion
Finely tuned ion influx and efflux result from various intricate interplays of multiple channels likely tailored for each type of cell and maturation status. The intriguing high expression of TMEM176A and TMEM176B cation channels in both RORgt + lymphoid cells and DCs logically raises the question of their specific role in these two very distinct immune cell types. Based on expression and functional data, we reasoned that each gene has the potential to compensate for each other and that simultaneous targeting would be a requisite to avoid such redundancy.
We present here the first functional study of Tmem176a/b double KO (DKO) mice, either germline or conditional. Given the broad tissue expression of Tmem176a/b, the "floxed" conditional mouse represents an invaluable tool to achieve Cre-mediated cell-specific deletion and document the role of these ion channels in virtually any tissue or cell of interest. Indeed, there is a growing interest in understanding the role of these homolog genes that are over-expressed in a wide range of cell types other than immune cells including fibroblast subsets 37 , neurons 38 , adipocytes 39 or tumor cells [40] [41] [42] , likely adapting a universal mechanism of intracellular ion flux regulation to their specific needs. Importantly, these Tmem176a/b DKO mice were generated directly in a pure genetic background (C57BL/6N) thus avoiding incorrect interpretations resulting from carryover of gene variants of a different background surrounding the targeted locus 43, 44 .
The striking expression of Tmem176a/b in all type 3 immune cells and their dependency on the master transcription factor RORgt 15 make these homologs promising candidates to uncover novel aspects of RORgt + cell biology beyond their cytokine production and could represent a novel therapeutic entry point for treating immune-mediated diseases. However, our results indicate that RORgt-dependent intestinal repair and host defense functions are not compromised in the absence of Tmem176a/b. Furthermore, the normal development MOG35-55 peptide-induced EAE suggest that these genes are not required for the pathogenicity of Th17 in this model. Investigating the transcriptomic and epigenetic profiles of purified DKO ILC3s or Th17 cells may expose compensatory mechanisms notably involving the regulation of other ion channels that could sufficiently counterbalance the absence of Tmem176a/b. It is also tempting to speculate that these homologs could be required for IL-17/IL-22-independent functions in RORgt + cells, including the regulation of anticommensal effector CD4 + T-cells by ILC3s through MHC II-mediated inhibitory presentation 45, 46 . Although Lancien et al.
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Tmem176a/b fl/fl Rorc-Cre +/conditional mice did not exhibit increased CD4 + T cell activation and proliferation nor neutrophil accumulation in the colonic lamina propria in comparison to control mice (data not shown), the fact that ILC3s selectively share with DCs the expression of MHC II molecules is in favor of a pivotal role of Tmem176a/b in this adaptive function.
In view of the recent study by Segovia et al. 29 using Tmem176b single KO mice or an ion channel inhibitory molecule, our results do not support the hypothesis that inhibiting TMEM176A/B-mediated ion flux could enhance anti-tumor CD8 + T-cell response in vivo. Moreover, we did not observe increased IL-1b production by Tmem176a/b-deficient BMDCs (data not shown). One can speculate that TMEM176B must be targeted alone, leaving TMEM176A function intact, to obtain such phenotype, and that the effect of the inhibitory molecule is therefore achieved in a selective manner. Alternatively, because of the 129 genetic background origin of the Tmem176b single KO mouse 5 , confounding genetic factors could be invoked, despite >10 backcrosses onto the C57BL/6 background and the use of littermates 47 .
We initially reported that Tmem176a/b were highly expressed in cDCs but not in pDCs 10, 17 , likely a consequence of E2-2-mediated repression as revealed by Ghosh et al. for Tmem176a 48 . Remarkably, recent mouse and human single-cell RNA-seq analysis highlighted these homologs as markers of selective DC subsets, both in mouse and human [49] [50] [51] . Notably, the association of TMEM176B expression with a subset of cDC2 in Binnewies et al. 51 is concordant with our data in the mouse showing that Tmem176a/b are markedly over-expressed in cDC2 compared to cDC1. cDC2 exhibit an overall dominance in MHC II presentation in vivo resulting from the combination of their intrinsic efficiency 28, 52 and their favorable position within lymphoid tissues for antigen uptake 53 . Consistently, we found that Tmem176a/b deficiency selectively affected the capacity of DCs to prime naive CD4 + T cells but not CD8 + T cells in vivo. Our results point to a defect in the intracellular processing events for exogenous antigen presentation to MHC II molecules. However, this functional alteration is not complete and it is possible that, in the same manner as in ILC3s, compensatory mechanisms develop in DCs in the absence of Tmem176a/b. In support of this hypothesis, the fact that H2-M was found selectively over-expressed in cDC2 of DKO mice suggests an adaptation to alleviate a defect in the MIIC for peptide loading onto MHC II molecules. Alternatively, this expression may also reflect an incorrect intracellular localization of H2-M, therefore disrupting the optimal processes leading to MHC II presentation.
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The analysis of TMEM176A/B intracellular dynamics enabled us to clearly delineate that they preferentially traffic in the late endolysosomal system in close relationship with the Golgi apparatus. In contrast with the limitations in sensitivity and the non-dynamic nature of classical immunostaining, the RUSH system was instrumental in revealing the route taken by TMEM176A/B from the ER and beyond the Golgi apparatus.
However, because we focused on the first hour of trafficking after release in most of our analyses, we cannot exclude that TMEM176A/B can eventually reach other compartments over time.
The strong colocalization found with HLA-DM in HeLa-CIITA cells supports the hypothesis of a direct role in the MIIC. TMEM176A/B-mediated cation (Na + ) efflux could participate in the regulated acidification of this compartment as a counterion conductance 54 . TMEM176A/B could be located on the limiting membrane of the MIIC or on intraluminal vesicles (ILVs) where a direct interaction with HLA-DM would be possible. In this regard, independently of their ion channel function, it is conceivable that these four-span transmembrane proteins act similarly to tetraspanin molecules to stabilize DM-MHC II interaction 55 . On the same note, given the reported genetic association between TMEM176A and HDL cholesterol levels in human 56 , TMEM176A/B function may be connected to cholesterol-containing microdomains for efficient MHC II trafficking 57 . High resolution imaging, FRET analysis or the characterization of organelle-specific disruption in DKO DCs could be informative to uncover the precise role of TMEM176A/B in the MHC II pathway.
In conclusion, while the intrinsic role of TMEM176A/B in RORgt + cells remains to be further explored, we found that these cation channels play a substantial role in the MHC II pathway to ensure optimal naive CD4 + T cell priming by DCs. Figure 4B ). WT DKO Video S1. Real-time imaging of the synchronized trafficking of TMEM176B using the RUSH system (corresponds to Figure 7C ). After 20 h of expression, at time 00:00, release of the reporter TMEM176B-SBP-EGFP was induced by addition of biotin and monitored using a spinning disk confocal microscope.
Video S2. Dual color, real-time imaging of the synchronized trafficking of TMEM176B and TMEM176A using the RUSH system (corresponds to Figure 7D ). After 20 h of expression, at time 00:00, release of the reporters TMEM176B-SBP-mCherry (red) and TMEM176A-SBP-EGFP (green) was induced by addition of biotin and monitored using a confocal microscope.
Video S3. Dual color, real-time imaging of the synchronized trafficking of TMEM176B and TMEM176A using the RUSH system (corresponds to Figure 7E ). After 20 h of expression, at time 00:00, release of the reporters TMEM176B-SBP-mCherry (red) and Golgin-84-SBP-EGFP (green) was induced by addition of biotin and monitored using a confocal microscope. Table S1 . Antibodies used in this study. Table S2 . Oligonucleotides used in this study. Table S3 . Plasmids used in this study.
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Methods
Mice
Tmem176a/b double KO (DKO) mice were generated by a dual targeting approach using the CRISPR-Cas9 system as previously described 20 . DKO mice used in this study were generated in the C57BL/6N genetic background. Three consecutive backcrosses with C57BL/6N mice were performed before intercrossing heterozygous mice. To control for cage-dependent microbiota variations, WT and DKO mice were systematically co-housed directly after weaning following sex-and age-matching.
Conditional OT-II.Ly5.1.Foxp3EGFP homozygous mice were obtained by intercrossing OVA-specific TCR-transgenic OT-II mice (C57BL/6-Tg(TcraTcrb)425Cbn/Crl) (Charles River) with Ly5.1 mice (B6.SJL-PtprcaPepcb/BoyCrl) (Charles River) and Foxp3EGFP reporter mice (generated by Bernard Malissen 61 ).
All mice used for experiments were between 8 and 25 weeks of age and kept under specific pathogen-free conditions. Experimental procedures were carried out in strict accordance with the protocols approved by the Lancien et al.
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Commitee on the Ethics of Animal Experiments of Pays de la Loire and authorized by the French Government's Ministry of Higher Education and Research.
Chemically-induced acute colitis
Mice were given 2% dextran sulfate sodium (DSS) (36,000-50,000 MW, MP Biomedical) in drinking water ad libitum for 7 days followed by a recovery period without DSS. Mice were monitored and weighed daily.
Citrobacter rodentium infection
Citrobacter rodentium (DBS100, ATCC 51459) were culture aerobically at 37°C overnight at 200 rpm in Luria-Bertani (LB) broth medium (MP Biomedicals) and then diluted 1:10 in fresh LB medium until the concentration of bacteria reached optical density 600. Mice were pre-treated with 750 mg/L metronidazole (Sigma) in 2.5% sucrose drinking water for 4 days as previously described 62 , followed by 3 days with regular drinking water. Mice were then fasted 8 h before the infection by oral gavage with 2´10 9 colony-forming units (CFUs) of C. rodentium resuspended in sterile 0.9% NaCl. Bacterial concentration was assessed via serial dilution on LB agar plates to confirm the CFUs administered. Mice were monitored and weighed daily. Faeces were collected at days 0 and 6 post-infection for detection of C. rodentium by qPCR.
Skin transplantation
Mice were anesthetized with a mixture of 5% xylazine (Rompun) and 18% ketamine in PBS (170 µL) injected intraperitoneally (8.5 mg/kg of xylazine and 76.5 mg/kg of ketamine per mouse). Square skin grafts (1 cm 2 )
were prepared from the tail of male donors and transplanted on the shaved left flank of female recipients. The grafts were fixed to the graft bed with 10-12 interrupted sutures and were covered with protective tape. Mice were monitored every other day and graft rejection was defined as complete sloughing or a dry scab.
Tumor growth models
EG7, MCA101-sOVA 63 (provided by Clotilde Théry) and B16-OVA tumor cells were recovered from log phase in vitro growth and 1´10 6 cells were injected subcutaneously in 50 µL of cold PBS into the flank skin of recipient mice. Tumor growth was measured in a blind fashion with a caliper and expressed as the area based on two perpendicular diameters. Mice were monitored daily and were euthanized when tumor size reached 289 mm 2 .
Lancien et al. 
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Delayed-type hypersensitivity (DTH) assay
Mice were immunized subcutaneously at the base of the tail and lower flanks with 50 µg of whole OVA protein (grade V, Sigma) or OVA323-339 (ISQAVHAAHAEINEAGR) peptide (GenScript) emulsified in complete Freund's adjuvant (Sigma). After 7 days, mice were challenged with 250 µg of heat-aggregated OVA (2 min incubation at 100°C) injected (20 µL, s.c.) in the right hind footpad whereas the left hind footpad received 250 µg of heat-aggregated BSA (Sigma) as a control for non-specific inflammation. Footpad thickness was measured prior to, 24 h and 48 h after injection with an electronic digital micrometer. The observer was blinded to the genotype during the scoring.
Flow cytometry analysis and cell sorting
Antibodies and panels used in this study for FACS analysis and cell sorting are listed in Supplementary   Table 1 . Red blood cells were lysed with ammonium chloride. Small intestine and colon lamina propria (siLP an cLP) cells were prepared as previously described 6 . Before all stainings, dead cells were marked for exclusion using Fixable Viability Dye eFluor 506 (eBioscience) or DAPI (Thermo Fisher Scientific) followed by Fc
